BRIEF published on 11/08/2024 at 07:35, 13 days 6 hours ago Bechtle Reports International Growth in Q3 Despite Economic Challenges International Growth Earnings Operating Cash Flow Bechtle AG Q3 2024
PRESS RELEASE published on 11/08/2024 at 07:30, 13 days 7 hours ago Bechtle shows international growth in third quarter Bechtle AG shows 2.2% revenue growth in Q3 2024, EBT totals €78.6 m. Operating cash flow increases to €289.4 m. 890 young people in training. Cost pressure impacts earnings Revenue Growth Cash Flow Bechtle AG EBT Young People In Training
BRIEF published on 10/22/2024 at 10:55, 30 days 3 hours ago Bechtle AG: Third-Quarter Earnings Below Expectations Bechtle AG Market Expectations Economic Conditions Investment Reluctance Third-quarter Earnings
PRESS RELEASE published on 10/22/2024 at 10:50, 30 days 3 hours ago EQS-Adhoc: Bechtle AG: Third-quarter earnings below expectations Bechtle AG reports third-quarter earnings below expectations, attributing it to market uncertainties and low investments, impacting revenue and earnings Revenue Bechtle AG EBT Market Expectations Third-quarter Earnings
BRIEF published on 08/09/2024 at 07:35, 3 months 12 days ago Bechtle optimistic for FY 2024 Cash Flow Business Volume Bechtle AG FY 2024 Forecast European M&A
PRESS RELEASE published on 08/09/2024 at 07:30, 3 months 12 days ago Bechtle optimistic for FY 2024 Bechtle AG remains optimistic for FY 2024 despite challenges in Q2. Operative cashflow doubles, moderate employee growth, and strategic plans for growth. CEO Dr. Thomas Olemotz confirms positive outlook Growth Strategy Bechtle AG Employee Growth FY 2024 Operative Cashflow
BRIEF published on 07/18/2024 at 12:04, 4 months 3 days ago Bechtle AG Revises Full-Year Forecast Public Sector Bechtle AG Q2 Results Forecast Revision SME Investment
PRESS RELEASE published on 07/18/2024 at 11:59, 4 months 3 days ago EQS-Adhoc: Bechtle AG: Full-year forecast revised Bechtle AG revises full-year forecast due to lower growth in Q2 2024, impacting revenue and earnings. Business volume up 1%, revenue down 2%. Earnings before taxes at €83 million Revenue Bechtle AG Q2 2024 Earnings Before Taxes Revised Forecast
BRIEF published on 05/08/2024 at 07:34, 6 months 13 days ago Bechtle AG Maintains Optimistic Outlook for 2024 Despite Mixed Quarterly Results Digital Transformation Bechtle AG Software Growth Q1 Financial Results 2024 Business Outlook
PRESS RELEASE published on 05/08/2024 at 07:29, 6 months 13 days ago Bechtle Affirms Forecast for the Year As a Whole Bechtle AG affirms forecast for the year as a whole with business volume up by 3.4% and strong software business driving performance. Operating cash flow and EBT show positive growth Forecast Operating Cash Flow Bechtle AG EBT Software Business
Published on 11/21/2024 at 14:15, 15 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 30 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 30 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 30 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 14 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 15 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 55 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 32 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 10 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 45 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 45 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
